Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
1.070
+0.030 (2.88%)
At close: May 12, 2025, 4:00 PM
1.130
+0.060 (5.61%)
After-hours: May 12, 2025, 7:59 PM EDT
FATE's stock price has decreased by -73.77% in the past year and price targets may not have had time to catch up.
Fate Therapeutics Analyst Ratings
Total Analysts
8
Consensus Rating
Hold
Price Target
$5.43
Upside
+407.48%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Hold Maintains $5 → $3 | Hold | Maintains | $5 → $3 | +180.37% | Mar 6, 2025 |
| Wedbush | Wedbush | Hold Reiterates $5 | Hold | Reiterates | $5 | +367.29% | Mar 6, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $5 → $4 | Hold | Maintains | $5 → $4 | +273.83% | Mar 6, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 6, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 19, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $5 | Hold | Reiterates | $5 | +367.29% | Aug 22, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 14, 2024 |
| Piper Sandler | Piper Sandler | Hold → Buy Upgrades $4 → $6 | Hold → Buy | Upgrades | $4 → $6 | +460.75% | Jun 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $7 → $5 | Hold | Maintains | $7 → $5 | +367.29% | May 16, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $11 → $9 | Strong Buy | Maintains | $11 → $9 | +741.12% | May 10, 2024 |
| BMO Capital | BMO Capital | Hold Maintains $7 → $6 | Hold | Maintains | $7 → $6 | +460.75% | May 10, 2024 |
| Wedbush | Wedbush | Hold Maintains $7 → $5 | Hold | Maintains | $7 → $5 | +367.29% | May 10, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $7 → $4 | Hold | Maintains | $7 → $4 | +273.83% | May 10, 2024 |
| Wedbush | Wedbush | Hold Reiterates $7 | Hold | Reiterates | $7 | +554.21% | May 6, 2024 |
| Wedbush | Wedbush | Hold Reiterates $7 | Hold | Reiterates | $7 | +554.21% | Apr 23, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.